Indefinite Delivery Contract SPM20005D0957

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply a wide range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The IDC, valued up to $999,999,999 through December 2025, serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive assortment of medications, including specialty drugs, brand-name and generic pharmaceuticals, vaccines, and critical care materials such as syringes and test kits. The contract has no set-aside designations and was awarded through full and open competition, leveraging AmerisourceBergen's extensive supply chain capabilities to fulfill the diverse medical needs of the Department of Defense and other federal healthcare providers. The contract is structured with numerous firm-fixed-price delivery orders issued over the period of performance, with the place of performance being Chesterbrook, Pennsylvania.

In addition to the large IDC with the DLA, AmerisourceBergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate AmerisourceBergen's capacity to serve as a critical supplier of essential pharmaceutical and medical commodities to various government agencies, supporting the healthcare requirements of military personnel, veterans, and other federal beneficiaries across multiple locations and healthcare settings.